962 related articles for article (PubMed ID: 18215703)
1. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
[TBL] [Abstract][Full Text] [Related]
2. Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after a two-year follow-up.
Scardi S; Mazzone C; Pandullo C; Goldstein D; Di Lenarda A; Chersevani D
G Ital Cardiol; 1999 Jun; 29(6):637-46. PubMed ID: 10396667
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
[TBL] [Abstract][Full Text] [Related]
4. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.
Alsheikh-Ali AA; Wang PJ; Rand W; Konstam MA; Homoud MK; Link MS; Estes NA; Salem DN; Al-Ahmad AM
Am Heart J; 2004 Jun; 147(6):1061-5. PubMed ID: 15199356
[TBL] [Abstract][Full Text] [Related]
5. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
Am J Med; 2010 Jul; 123(7):646-51. PubMed ID: 20609687
[TBL] [Abstract][Full Text] [Related]
6. Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation.
Sharma S; Gage BF; Deych E; Rich MW
Am Heart J; 2009 Jun; 157(6):1057-63. PubMed ID: 19464417
[TBL] [Abstract][Full Text] [Related]
7. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
[TBL] [Abstract][Full Text] [Related]
8. Comparison of evidence-based versus non-evidence-based pharmacotherapy on the risk of cardiovascular hospitalization and all-cause mortality among patients with established cardiovascular disease.
Nichols GA; Wang F; Pedula KL
Am J Cardiol; 2010 Mar; 105(6):786-91. PubMed ID: 20211320
[TBL] [Abstract][Full Text] [Related]
9. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
[TBL] [Abstract][Full Text] [Related]
11. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
Buch P; Rasmussen S; Abildstrom SZ; Køber L; Carlsen J; Torp-Pedersen C;
Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070
[TBL] [Abstract][Full Text] [Related]
12. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study.
Miyasaka Y; Barnes ME; Bailey KR; Cha SS; Gersh BJ; Seward JB; Tsang TS
J Am Coll Cardiol; 2007 Mar; 49(9):986-92. PubMed ID: 17336723
[TBL] [Abstract][Full Text] [Related]
13. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
Salehian O; Healey J; Stambler B; Alnemer K; Almerri K; Grover J; Bata I; Mann J; Matthew J; Pogue J; Yusuf S; Dagenais G; Lonn E;
Am Heart J; 2007 Sep; 154(3):448-53. PubMed ID: 17719288
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin inhibition in renovascular disease: a population-based cohort study.
Hackam DG; Duong-Hua ML; Mamdani M; Li P; Tobe SW; Spence JD; Garg AX
Am Heart J; 2008 Sep; 156(3):549-55. PubMed ID: 18760140
[TBL] [Abstract][Full Text] [Related]
15. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
16. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
17. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up.
Berton G; Cordiano R; Cucchini F; Cavuto F; Pellegrinet M; Palatini P
Int J Clin Pract; 2009 May; 63(5):712-21. PubMed ID: 19392921
[TBL] [Abstract][Full Text] [Related]
19. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.
L'Allier PL; Ducharme A; Keller PF; Yu H; Guertin MC; Tardif JC
J Am Coll Cardiol; 2004 Jul; 44(1):159-64. PubMed ID: 15234426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
